Free Trial
NYSE:PHG

Koninklijke Philips Q3 2025 Earnings Report

Koninklijke Philips logo
$27.53 +0.20 (+0.72%)
Closing price 03:59 PM Eastern
Extended Trading
$27.15 -0.38 (-1.38%)
As of 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Koninklijke Philips EPS Results

Actual EPS
N/A
Consensus EPS
$0.37
Beat/Miss
N/A
One Year Ago EPS
N/A

Koninklijke Philips Revenue Results

Actual Revenue
N/A
Expected Revenue
$4.30 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Koninklijke Philips Announcement Details

Quarter
Q3 2025
Time
Before Market Opens
Conference Call Date
Tuesday, November 4, 2025
Conference Call Time
1:00AM ET

Conference Call Resources

Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Koninklijke Philips? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Koninklijke Philips and other key companies, straight to your email.

About Koninklijke Philips

Koninklijke Philips (NYSE:PHG) (NYSE: PHG) is a global technology company specializing in health and well-being. Founded in 1891 in Eindhoven, the Netherlands, Philips has evolved from its early focus on lighting and electronics into a leading health technology provider. Headquartered in Amsterdam, the company develops a comprehensive portfolio of products and solutions aimed at improving patient outcomes and enabling more efficient care delivery.

Philips operates through two main segments: Diagnosis & Treatment and Connected Care & Personal Health. The Diagnosis & Treatment segment offers advanced imaging systems, including magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound, as well as informatics solutions for radiology and oncology. The Connected Care & Personal Health segment provides patient monitoring systems, defibrillators, respiratory care devices, sleep and respiratory therapeutics, and a range of consumer health products such as electric toothbrushes and grooming tools. Across its portfolio, Philips places a strong emphasis on digital health platforms, artificial intelligence and data analytics, designed to support remote monitoring and telehealth services.

With operations in more than 100 countries, Philips serves hospitals, clinics, home care providers and individual consumers around the world. The company maintains R&D centers in Europe, the Americas and Asia, collaborating with healthcare institutions and academic partners to accelerate innovation in areas such as precision diagnostics and minimally invasive therapies. In recent years, Philips has undertaken strategic divestments to sharpen its focus on health technology and ensure sustained investment in research and development.

Roy Jakobs, who assumed the role of Chief Executive Officer in October 2022, leads a management team committed to advancing Philips’ vision of “making the world healthier and more sustainable through innovation.” Under his leadership, the company continues to pursue strategic partnerships, enhance its digital health offerings and expand access to its solutions globally, with a goal of addressing the pressing challenges of aging populations and constrained healthcare resources.

View Koninklijke Philips Profile

More Earnings Resources from MarketBeat